Background illustration for clinical trials search

Paid Clinical Trials Buffalo

Discover 779 paid clinical trials in Buffalo, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Patient Navigation Program for Addressing Disparities in Breast Cancer Care

for
Breast Carcinoma, Breast Ductal Carcinoma in Situ
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute

Sex: Female

Age: 18+

Code: NCT06350500

Recruiting

Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction

for
Malignant Solid Neoplasm
Location: Buffalo NY, Philadelphia PA
Sponsor: Roswell Park Cancer Institute

Sex: All

Age: 18+

Code: NCT06306638

Phase 1, Phase 2, Recruiting

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

for
Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation,
Location: Buffalo NY, Cleveland OH, Detroit MI, Ann Arbor MI,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05735184

Phase 1, Recruiting

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

for
Non Small Cell Lung Cancer, Triple Negative Breast Cancer,
Location: Buffalo NY, Fort Wayne IN, Boston MA, Nashville TN,
Sponsor: Compass Therapeutics

Sex: All

Age: 18+

Code: NCT06150664

Phase 1, Recruiting

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer,
Location: Buffalo NY, Hamilton, Toronto, Cleveland OH, Detroit MI,
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All

Age: 18+

Code: NCT06343402

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer

for
Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC)
Location: Buffalo NY, Cleveland OH, Detroit MI, New Brunswick NJ,
Sponsor: J-Pharma Co., Ltd.

Sex: All

Age: 18+

Code: NCT07265674

Phase 3, Recruiting

Quality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung Cancer

for
Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8,
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute

Sex: All

Age: 18+

Code: NCT05292521

Recruiting

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

for
Cancer, Solid Tumor, Melanoma, Renal Cell Carcinoma,
Location: Buffalo NY, New Haven CT, Boston MA, Denver CO,
Sponsor: Simcha IL-18, Inc.

Sex: All

Age: 18+

Code: NCT04787042

Phase 1, Phase 2, Recruiting

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

for
Endometrial Cancer
Location: Buffalo NY, Hamilton, Toronto, Mississauga, Barrie,
Sponsor: Canadian Cancer Trials Group

Sex: Female

Age: 18+

Code: NCT05640999

Phase 2, Recruiting

Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.

for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Buffalo NY, Boston MA, Duarte CA, Irvine CA,
Sponsor: City of Hope Medical Center

Sex: All

Age: 70+

Code: NCT04305834

Phase 2, Recruiting

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

for
Myelodysplastic Syndrome
Location: Buffalo NY, Danville PA, Pittsburgh PA, Wilkes-Barre PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06577441

Phase 2, Recruiting

Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation

for
Chronic Phase Chronic Myelogenous Leukemia
Location: Buffalo NY, Detroit MI, New York NY, Milwaukee WI,
Sponsor: Medical College of Wisconsin

Sex: All

Age: 18+

Code: NCT04838041

Phase 2, Recruiting

Empathic Communication Skills (ECS) Training

for
Lung Cancer
Location: Buffalo NY, Philadelphia PA, Hackensack NJ, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT05456841

Recruiting

Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study

for
Chronic Graft-versus-Host-Disease, Leukemia,
Location: Buffalo NY, New York NY, Columbus OH, Montreal,
Sponsor: University of British Columbia

Sex: All

Age: 0 - 24

Code: NCT04372524

Recruiting

Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Cancer

for
Breast Carcinoma, Head and Neck Cancer, Lung Cancer
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute

Sex: All

Age: 21+

Code: NCT05787834

Recruiting

Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

for
Metastatic Bone Sarcoma,
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute

Sex: All

Age: 18+

Code: NCT03965234

Phase 1, Phase 2, Recruiting

ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML

for
B-cell Acute Lymphoblastic Leukemia,
Location: Buffalo NY, Boston MA, Chicago IL
Sponsor: Marlise Luskin, MD

Sex: All

Age: 18+

Code: NCT03595917

Phase 1, Recruiting

Study of SGR-1505 in Mature B-Cell Neoplasms

for
Mature B-Cell Neoplasm, Non Hodgkin Lymphoma, DLBCL,
Location: Buffalo NY, Canton OH, Newark DE, Hackensack NJ,
Sponsor: Schrödinger, Inc.

Sex: All

Age: 18+

Code: NCT05544019

Phase 1, Recruiting

Single-Fraction SBRT Versus Standard Palliative Radiation Therapy in Treating Patients With Metastatic Cancer

for
Metastatic Malignant Neoplasm
Location: Buffalo NY, East Hills NY, West Islip NY
Sponsor: Roswell Park Cancer Institute

Sex: All

Age: 18+

Code: NCT04068649

Phase 2, Recruiting

A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Buffalo NY, Toronto, Hackensack NJ, New York NY,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06121843

Phase 1, Recruiting